Article Versions Notes

Li Y, Xing A, Li W, Zhang Y, Zhang K, Xie T, Wu G, Zhang W. A Pan-Cancer Multi-Omics Analysis of CAD: Integrating CRISPR and Metabolomics Data to Unravel the Metabolic–Immune Axis and Immunotherapy Response. Biomedicines. 2026; 14(6):1218. https://doi.org/10.3390/biomedicines14061218

Li, Yiyan, Aoxue Xing, Wenzheng Li, Yiman Zhang, Kejuan Zhang, Tianhao Xie, Gang Wu, and Wei Zhang. 2026. "A Pan-Cancer Multi-Omics Analysis of CAD: Integrating CRISPR and Metabolomics Data to Unravel the Metabolic–Immune Axis and Immunotherapy Response" Biomedicines 14, no. 6: 1218. https://doi.org/10.3390/biomedicines14061218

Li, Y., Xing, A., Li, W., Zhang, Y., Zhang, K., Xie, T., Wu, G., & Zhang, W. (2026). A Pan-Cancer Multi-Omics Analysis of CAD: Integrating CRISPR and Metabolomics Data to Unravel the Metabolic–Immune Axis and Immunotherapy Response. Biomedicines, 14(6), 1218. https://doi.org/10.3390/biomedicines14061218